The Board of CellaVision has appointed Zlatko Rihter as CEO of CellaVision. Zlatko Rihter has extensive experience in the international medical technology industry through various senior executive positions in the areas of business development, sales, marketing, research and IT. Currently Zlatko Rihter serves as Executive Vice President and head of global sales and marketing at Origio A/S. After an initial career in the medical technology industry in business development and innovation Zlatko Rihter has in the past ten years focused on the commercial side. His experience includes senior executive positions in global business and product divisions at ArjoHuntleigh (Getinge) and Gambro where he was the president of EMEA Sales for 2012-2013. Zlatko Rihter's most recent position is as Executive Vice President of Origio A/S with the responsibility of worldwide marketing and sales, with $ 120 million in sales and 200 employees spread over 15 subsidiary offices. Zlatko Rihter is M. Sc. Mechanical Engineering from Lund University with studies in financial economics from Lund University. "We are very pleased to welcome Zlatko Rihter in the role of CEO at CellaVision" says Lars Gatenbeck, Chairman of the Board at CellaVision. "Zlatko Rihter's deep and extensive experience from the medical technology industry and his exceptionally broad strategic and international business background make him a perfect fit for this role. Together with CellaVision's strong management team he can take the company to the next phase of its development with continued strong expansion and diversification of its business." "Yvonne Mårtensson has done a fantastic job during her sixteen years as CEO at CellaVision. Under her leadership CellaVision has evolved into a global medical technology company and a world leader in its field, digital microscopy of Hematology." adds Lars Gatenbeck. "I'm excited to take on the responsibility of CellaVision, a well-managed and prosperous company with a good reputation. As the new president, I look forward to working with CellaVision's strong team and based on today's successful core business developing the company to a new level. "says Zlatko Rihter Zlatko Rihter starts his assignment as CEO for CellaVision no later than February the 1(st) 2015, succeeding Yvonne Mårtensson which, according to previous information, is leaving CellaVision. The Board would like to thank Yvonne Mårtensson who has been the CEO of CellaVision since 1998. Lars Gatenbeck Chairman of the Board For more information, please contact: Lars Gatenbeck, Chairman of the Board, CellaVision AB Tel: +46 (0) 70-535 44 44 | Email: lars.gatenbeck@lifeequity.se Maria Morin, VP HR & Corporate Communications, CellaVision AB Tel: +46 (0) 70-992 62 28| Email: maria.morin@cellavision.se About CellaVision CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses, for example of infections and serious cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2013 sales were SEK 180 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com. [HUG#1867838]
CellaVision AB : Zlatko Rihter appointed new President/CEO
Top 10 Most Recent News Articles
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP
Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...
Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal
Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...
Continue Reading
Hexaware’s Seven-Year Client Signal Is Worth Watching
Seven straight years of recognition is harder to shrug off than one shiny plaque on a corporate shelf. Hexaware Technologies announced on November 18, 2026 that it received the ISG Star of Excellence Award in the Client Champion category, marking its seventh consecutive year of recognition in that awards program. For investors following IT services, that is a...
Continue Reading
Paladone Tests LEGO's Everyday Collectibles Pull Abroad
A glowing minifigure lamp is not exactly a macroeconomic event, but licensed merchandise has a funny way of revealing where household spending still has a pulse. Paladone Products has put its first LEGO-branded collection into stores, a modest-looking launch with some real retail logic behind it. This is not a grand toy-box bet on one blockbuster item. It is a spread of...
Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team
Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...
Continue Reading
Trinity's Minneapolis Move Signals Freight Momentum
A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...
Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons
Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...
Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor
Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...
Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless
A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...
Continue Reading
Century's Florence Model Openings Put Arizona in Focus
Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...
Continue ReadingTop 5 Most Recently Viewed Articles
Symbotic Inc. Faces Legal Challenges Amid Financial Irregularities
Symbotic Inc. Under Investigation for Securities Violations There has been a significant development for investors of Symbotic Inc. As concerns about the Company’s financial practices have arisen, the Schall Law Firm has initiated an investigation. This effort is aimed at ensuring shareholders are informed and protected amid allegations of misleading statements related...
Continue Reading
Turning Point Brands: Growth Opportunities Ahead with New Rating
Turning Point Brands Gets a Positive Buy Rating Recently, Turning Point Brands (NYSE: TPB) earned a favorable Buy rating from Roth/MKM, along with a price target set at $50. This company is known for its wide range of consumer brands in the nicotine, tobacco, and cannabis markets, particularly recognized for its popular rolling papers and moist snuff products. Growth in...
Continue Reading
NeuroSense Therapeutics Celebrates Key Manufacturing Milestone
NeuroSense Therapeutics Achieves Commercial Manufacturing Scale-Up NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a pioneering biotechnology firm dedicated to developing innovative treatments for severe neurodegenerative diseases, has announced a major milestone in its commercial journey. The company has successfully scaled up its production of PrimeC, preparing for...
Continue Reading
Discover the Potential of Azapeptides in Peptide Stability
Unveiling the Future of Peptide Stability with Azapeptide Synthesis In this informative webinar, participants will discover how strategies involving azapeptides can significantly enhance the stability of peptides and improve workflows related to synthesis. Attendees will delve into techniques for incorporating aza-amino acids within peptides that utilize traditional amino...
Continue Reading
Ascent Solar Technologies Faces Major Challenges in Market
Ascent Solar Technologies Hits 52-Week Low Ascent Solar Technologies, recognized for its cutting-edge thin-film photovoltaic modules, is currently going through a challenging period. The company's stock has reached a 52-week low of $2.32, reflecting an astonishing nearly 99.6% decline over the past year. This drastic drop underscores the significant hurdles the company...
Continue Reading